Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dimitri Hemelsoet

Showing results (71-80 of 84) with videos related to

Pageof 9
Sort By:
Stroke|May 22, 2025
Prior Reperfusion Strategy Does Not Modify Outcome in Early Versus Late Start of Anticoagulants in Patients With Ischemic Stroke: Prespecified Subanalysis of the Randomized Controlled ELAN TrialAnke Wouters, Jelle Demeestere, Jean-Benoît Rossel, et al.
Intensive Care Medicine|September 4, 2024
Coaching doctors to improve ethical decision-making in adult hospitalized patients potentially receiving excessive treatment. The CODE stepped-wedge cluster randomized controlled trialDominique D Benoit, Aglaja De Pauw, Celine Jacobs, et al.
Communications Medicine|March 6, 2026
Patient-specific alterations in blood plasma cfRNA profiles enable accurate classification of cancer patients and controlsAnnelien Morlion, Philippe Decruyenaere, Kathleen Schoofs, et al.
Journal of Stroke|June 10, 2025
Impact of Stroke Severity and Vascular Risk Factors on Early Versus Late Anticoagulation in Patients With Stroke and Atrial FibrillationMasatoshi Koga, Mattia Branca, Daniel Strbian, et al.
Plos One|December 8, 2025
Coaching doctors to improve ethical decision-making in adult hospitalized patients potentially receiving excessive treatment: Process evaluation study of the CODE intervention in doctors and nurses working in ten acute hospital wardsRuth Piers, Let Dillen, Katrijn Goethals, et al.
European Stroke Journal|January 30, 2026
Once- versus twice-daily direct oral anticoagulants after ischemic stroke in atrial fibrillation - A post-hoc analysis of the ELAN trialAlexandros A Polymeris, Jean-Benoît Rossel, Masatoshi Koga, et al.
European Stroke Journal|August 11, 2025
Once- versus twice-daily direct oral anticoagulants after ischemic stroke in atrial fibrillation - A post-hoc analysis of the ELAN trialAlexandros A Polymeris, Jean-Benoît Rossel, Masatoshi Koga, et al.
Nature Genetics|November 3, 2023
Loss of phospholipase PLAAT3 causes a mixed lipodystrophic and neurological syndrome due to impaired PPARγ signalingNika Schuermans, Salima El Chehadeh, Dimitri Hemelsoet, et al.
Cell Reports|December 30, 2020
Charting Extracellular Transcriptomes in The Human Biofluid RNA AtlasEva Hulstaert, Annelien Morlion, Francisco Avila Cobos, et al.
American Journal of Human Genetics|September 8, 2018
IRF2BPL Is Associated with Neurological PhenotypesPaul C Marcogliese, Vandana Shashi, Rebecca C Spillmann, et al.
Pageof 9

Showing results (71-80 of 84) with videos related to

Sort By:
Pageof 9
Stroke|May 22, 2025
Prior Reperfusion Strategy Does Not Modify Outcome in Early Versus Late Start of Anticoagulants in Patients With Ischemic Stroke: Prespecified Subanalysis of the Randomized Controlled ELAN TrialAnke Wouters, Jelle Demeestere, Jean-Benoît Rossel, et al.
Intensive Care Medicine|September 4, 2024
Coaching doctors to improve ethical decision-making in adult hospitalized patients potentially receiving excessive treatment. The CODE stepped-wedge cluster randomized controlled trialDominique D Benoit, Aglaja De Pauw, Celine Jacobs, et al.
Communications Medicine|March 6, 2026
Patient-specific alterations in blood plasma cfRNA profiles enable accurate classification of cancer patients and controlsAnnelien Morlion, Philippe Decruyenaere, Kathleen Schoofs, et al.
Journal of Stroke|June 10, 2025
Impact of Stroke Severity and Vascular Risk Factors on Early Versus Late Anticoagulation in Patients With Stroke and Atrial FibrillationMasatoshi Koga, Mattia Branca, Daniel Strbian, et al.
Plos One|December 8, 2025
Coaching doctors to improve ethical decision-making in adult hospitalized patients potentially receiving excessive treatment: Process evaluation study of the CODE intervention in doctors and nurses working in ten acute hospital wardsRuth Piers, Let Dillen, Katrijn Goethals, et al.
European Stroke Journal|January 30, 2026
Once- versus twice-daily direct oral anticoagulants after ischemic stroke in atrial fibrillation - A post-hoc analysis of the ELAN trialAlexandros A Polymeris, Jean-Benoît Rossel, Masatoshi Koga, et al.
European Stroke Journal|August 11, 2025
Once- versus twice-daily direct oral anticoagulants after ischemic stroke in atrial fibrillation - A post-hoc analysis of the ELAN trialAlexandros A Polymeris, Jean-Benoît Rossel, Masatoshi Koga, et al.
Nature Genetics|November 3, 2023
Loss of phospholipase PLAAT3 causes a mixed lipodystrophic and neurological syndrome due to impaired PPARγ signalingNika Schuermans, Salima El Chehadeh, Dimitri Hemelsoet, et al.
Cell Reports|December 30, 2020
Charting Extracellular Transcriptomes in The Human Biofluid RNA AtlasEva Hulstaert, Annelien Morlion, Francisco Avila Cobos, et al.
American Journal of Human Genetics|September 8, 2018
IRF2BPL Is Associated with Neurological PhenotypesPaul C Marcogliese, Vandana Shashi, Rebecca C Spillmann, et al.
Pageof 9